⚕️
Medikal Tanı ve Test Sektörü Hisseleri
Medikal Tanı ve Test Sektörü altında 235 Hisse Senedi
Medikal Tanı ve Test sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.
235
Toplam Hisse
$2.2T
Toplam Piyasa Değeri
Medikal Tanı ve Test Sektörü Hisseleri
Sayfa 1/3 (Toplam: 235)
| SEMBOL | ŞİRKET | PİYASA DEĞERİ | FİYAT | DEĞİŞİM | |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Company | $680.94B | $737.67 | 2.09% | |
| ABT | Abbott Laboratories | $224.53B | $133.58 | 0.55% | |
| TMO | Thermo Fisher Scientific Inc. | $154.81B | $402.82 | 0.23% | |
| BSX | Boston Scientific Corporation | $152.31B | $105.26 | 0.73% | |
| DHR | Danaher Corporation | $138.23B | $189.90 | 0.30% | |
| VRTX | Vertex Pharmaceuticals Incorporated | $108.79B | $442.05 | 1.13% | |
| MDT | Medtronic plc | $108.18B | $82.98 | 0.69% | |
| ZTS | Zoetis Inc. | $68.82B | $168.63 | 0.89% | |
| REGN | Regeneron Pharmaceuticals, Inc. | $60.44B | $490.28 | 19.01% | |
| EW | Edwards Lifesciences Corporation | $44.96B | $78.22 | 0.63% | |
| IDXX | IDEXX Laboratories, Inc. | $40.97B | $513.36 | 0.42% | |
| ALNY | Alnylam Pharmaceuticals, Inc. | $34.80B | $304.56 | 3.98% | |
| GEHC | GE HealthCare Technologies Inc. | $33.56B | $70.54 | 1.38% | |
| DXCM | DexCom, Inc. | $33.30B | $85.80 | 1.11% | |
| NTRA | Natera, Inc. | $20.57B | $157.73 | 0.20% | |
| LH | Laboratory Corporation of America Holdings | $20.41B | $248.97 | 0.90% | |
| DGX | Quest Diagnostics Incorporated | $19.32B | $173.34 | 0.78% | |
| ILMN | Illumina, Inc. | $12.56B | $82.24 | 2.42% | |
| HOLX | Hologic, Inc. | $12.44B | $62.17 | 1.19% | |
| SOLV | Solventum Corporation | $12.26B | $73.09 | 0.66% | |
| EXEL | Exelixis, Inc. | $12.15B | $43.04 | 1.03% | |
| TEM | Tempus AI, Inc. | $10.99B | $55.18 | 1.38% | |
| DVA | DaVita Inc. | $10.74B | $136.26 | 0.05% | |
| EXAS | Exact Sciences Corporation | $9.93B | $56.28 | 2.33% | |
| AVTR | Avantor, Inc. | $9.06B | $12.91 | 1.00% | |
| HSIC | Henry Schein, Inc. | $8.54B | $69.99 | 2.76% | |
| MEDP | Medpace Holdings, Inc. | $8.47B | $294.90 | 0.72% | |
| CHE | Chemed Corporation | $8.17B | $574.84 | 0.29% | |
| TECH | Bio-Techne Corporation | $7.56B | $48.40 | 0.14% | |
| RGEN | Repligen Corporation | $7.19B | $118.07 | 3.47% | |
| BIO | Bio-Rad Laboratories, Inc. | $6.88B | $226.93 | 0.30% | |
| BPMC | Blueprint Medicines Corporation | $6.42B | $101.35 | 1.66% | |
| BBIO | BridgeBio Pharma, Inc. | $6.32B | $34.25 | 2.64% | |
| BRKR | Bruker Corporation | $5.87B | $36.70 | 1.50% | |
| LNTH | Lantheus Holdings, Inc. | $5.40B | $75.56 | 0.05% | |
| IONS | Ionis Pharmaceuticals, Inc. | $5.18B | $33.51 | 0.15% | |
| GH | Guardant Health, Inc. | $5.10B | $40.62 | 5.37% | |
| ADMA | ADMA Biologics, Inc. | $4.75B | $19.84 | 0.35% | |
| IRTC | iRhythm Technologies, Inc. | $4.50B | $140.50 | 1.22% | |
| RDNT | RadNet, Inc. | $4.47B | $57.49 | 4.17% | |
| PTCT | PTC Therapeutics, Inc. | $3.75B | $48.52 | 0.76% | |
| SHC | Sotera Health Company | $3.66B | $12.24 | 1.13% | |
| HAE | Haemonetics Corporation | $3.45B | $67.71 | 0.19% | |
| RNA | Avidity Biosciences, Inc. | $3.40B | $30.98 | 2.27% | |
| RARE | Ultragenyx Pharmaceutical Inc. | $3.27B | $34.03 | 2.85% | |
| AMED | Amedisys, Inc. | $3.10B | $94.07 | 0.14% | |
| NVST | Envista Holdings Corp | $3.06B | $18.27 | 1.03% | |
| SRRK | Scholar Rock Holding Corporation | $2.93B | $29.01 | 2.78% | |
| CON | Concentra Group Holdings Parent, Inc. | $2.73B | $21.63 | 0.19% | |
| QDEL | QuidelOrtho Corporation | $2.29B | $30.67 | 0.26% | |
| IBRX | ImmunityBio, Inc. | $2.25B | $2.66 | 2.31% | |
| APLS | Apellis Pharmaceuticals, Inc. | $2.17B | $16.93 | 2.76% | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $2.10B | $16.07 | 4.46% | |
| ARDT | Ardent Health Partners, LLC | $2.08B | $14.48 | 1.50% | |
| DNLI | Denali Therapeutics Inc. | $2.05B | $13.24 | 2.22% | |
| CERT | Certara, Inc. | $1.97B | $11.36 | 0.35% | |
| BLTE | Belite Bio, Inc | $1.94B | $64.87 | 1.17% | |
| KYMR | Kymera Therapeutics, Inc. | $1.93B | $29.64 | 2.02% | |
| PGNY | Progyny, Inc. | $1.87B | $21.50 | 0.75% | |
| FOLD | Amicus Therapeutics, Inc. | $1.86B | $6.07 | 2.25% | |
| CGON | CG Oncology, Inc. Common stock | $1.85B | $25.62 | 2.33% | |
| TWST | Twist Bioscience Corporation | $1.77B | $29.30 | 1.42% | |
| RXRX | Recursion Pharmaceuticals, Inc. | $1.74B | $4.18 | 6.07% | |
| ASTH | Astrana Health, Inc. | $1.50B | $24.79 | 1.68% | |
| IDYA | IDEAYA Biosciences, Inc. | $1.49B | $19.89 | 0.80% | |
| ADPT | Adaptive Biotechnologies Corporation | $1.41B | $9.52 | 2.26% | |
| NEOG | Neogen Corporation | $1.32B | $5.86 | 5.64% | |
| TDOC | Teladoc Health, Inc. | $1.29B | $6.92 | 0.86% | |
| AZTA | Azenta, Inc. | $1.28B | $26.72 | 2.23% | |
| MD | Pediatrix Medical Group, Inc. | $1.23B | $14.15 | 0.56% | |
| GRAL | GRAIL, Inc. | $1.19B | $38.41 | 6.54% | |
| KMTS | Kestra Medical Technologies, Ltd. Common Stock | $1.14B | $22.52 | 0.75% | |
| TXG | 10x Genomics, Inc. | $1.14B | $9.53 | 2.09% | |
| DVAX | Dynavax Technologies Corporation | $1.13B | $9.79 | 0.31% | |
| OPK | OPKO Health, Inc. | $1.02B | $1.36 | 0.00% | |
| GYRE | Gyre Therapeutics, Inc. | $1.00B | $9.07 | 4.12% | |
| NVAX | Novavax, Inc. | $954.00M | $7.34 | 2.09% | |
| RCUS | Arcus Biosciences, Inc. | $898.96M | $8.93 | 6.10% | |
| CDNA | CareDx, Inc | $898.13M | $16.99 | 2.60% | |
| NUTX | Nutex Health, Inc. | $820.31M | $167.74 | 1.40% | |
| GERN | Geron Corporation | $777.04M | $1.52 | 2.70% | |
| PRAX | Praxis Precision Medicines, Inc. | $741.64M | $38.55 | 0.26% | |
| NRIX | Nurix Therapeutics, Inc. | $727.67M | $10.63 | 0.09% | |
| NUVB | Nuvation Bio Inc. | $717.54M | $2.12 | 6.19% | |
| BCAX | Bicara Therapeutics Inc. Common Stock | $711.15M | $9.25 | 2.01% | |
| MLAB | Mesa Laboratories, Inc. | $664.48M | $100.62 | 3.84% | |
| IMNM | Immunome, Inc. | $656.07M | $8.76 | 2.12% | |
| FLGT | Fulgent Genetics, Inc. | $613.44M | $20.72 | 0.53% | |
| ABUS | Arbutus Biopharma Corporation | $610.82M | $3.36 | 2.33% | |
| CBLL | CeriBell, Inc. | $599.97M | $16.81 | 1.23% | |
| BFLY | Butterfly Network, Inc. | $588.55M | $2.40 | 1.23% | |
| AVNS | Avanos Medical, Inc. | $587.76M | $12.57 | 0.55% | |
| BBNX | Beta Bionics, Inc. | $572.30M | $17.24 | 12.24% | |
| RGLS | Regulus Therapeutics Inc. | $543.14M | $7.93 | 0.13% | |
| KROS | Keros Therapeutics, Inc. | $539.78M | $14.15 | 0.93% | |
| EHAB | Enhabit, Inc. | $529.92M | $10.50 | 1.65% | |
| KURA | Kura Oncology, Inc. | $489.58M | $5.69 | 2.23% | |
| DNA | Ginkgo Bioworks Holdings, Inc. | $470.60M | $6.95 | 4.14% | |
| CGEM | Cullinan Oncology, Inc. | $449.69M | $8.64 | 0.40% | |
| BVS | Bioventus Inc. | $433.98M | $6.48 | 1.22% |